Clinical Trial Update: A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TQH2722 injection in moderate to severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• TQH2722 (TQH2722)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: UNKNOWN